Professor David Sinclair

Contact Details

Phone: (+61) 2 9385 1621


  • PHD
  • Masters
  • Honours


David Sinclair, Ph.D. is a Professor at the School of Medicine at The University of New South Wales (UNSW), Sydney, and co-founder and co-chief editor of the scientific journal Aging. He is also a Professor in the Genetic Department at Harvard Medical School, Boston, Co-Director of the Paul F. Glenn Laboratories for the Biological Mechanisms of Aging.

He obtained a BS and a Ph.D. at UNSW in Molecular Genetics with Ian Dawes, worked as a postdoctoral researcher at M.I.T. with Lenny Guarente, before being hired at Harvard Medical School in 1999. He was promoted to tenured Professor in 2008.

Dr. Sinclair's awards include the Australian Commonwealth Prize, a Helen Hay Whitney Postdoctoral Award, a Special Fellowship from the Leukemia Society, a Ludwig Scholarship, a Harvard-Armenise Fellowship, an American Association for Aging Research Fellowship, the Ellison Medical Foundation Scholarship and Senior Fellowship, the Genzyme Outstanding Achievement in Biomedical Science Award, Teluride Technology Award, Innovator of the Year, a MERIT Award from the NIA, the Nathan Shock Award, the David Murdock-Dole Lectureship, Excellence in Teaching at Harvard Medical School, the Fisher Lectureship, the Denham Harman Research Award, the ASMR Medal (Australian Society for Medical Research).

He cofounded Sirtris Pharmaceuticals (Cambridge, MA; NASDAQ:SIRT), Genocea Biosciences (Cambridge, MA; NASDAQ:GNCA), OvaScience (Cambridge, MA; NASDAQ:OVAS), Cohbar and MetroBiotech and is a consultant for GlaxoSmithKline, InsideTracker, Metrobiotech, and Ovascience.

University role



Laboratory for Ageing Research Level 3 | Wallace Wurth Building C25 University of New South Wales Sydney | NSW | 2052 | Australia